Watching Cerevel Therapeutics; Traders Circulating M&A Blog Comments Saying A Recommendation Memo From The Staff At The FTC To "Challenge" The CERE/ABBV Merger Is Being Considered
Watching Cerevel Therapeutics; Traders Circulating M&A Blog Comments Saying A Recommendation Memo From The Staff At The FTC To "Challenge" The CERE/ABBV Merger Is Being Considered
觀察Cerevel Therapeutics；交易員正在傳遞M & A博客評論，稱FTC的員工建議備忘錄正在考慮“挑戰”CERE / ABBV合併。
Watching Cerevel Therapeutics; Traders Circulating M&A Blog Comments Saying A Recommendation Memo From The Staff At The FTC To "Challenge" The CERE/ABBV Merger Is Being Considered
觀察Cerevel Therapeutics；交易員正在傳遞M & A博客評論，稱FTC的員工建議備忘錄正在考慮“挑戰”CERE / ABBV合併。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。